Yoseph Shaaltiel

2014

In 2014, Yoseph Shaaltiel earned a total compensation of $775.9K as Executive Vice President, Research and Development at Protalix BioTherapeutics, a 28% decrease compared to previous year.

Compensation breakdown

Bonus$90,000
Option Awards$62,651
Salary$305,548
Stock Awards$232,979
Other$84,719
Total$775,897

Shaaltiel received $305.5K in salary, accounting for 39% of the total pay in 2014.

Shaaltiel also received $90K in bonus, $62.7K in option awards, $233K in stock awards and $84.7K in other compensation.

Rankings

In 2014, Yoseph Shaaltiel's compensation ranked 8,656th out of 13,032 executives tracked by ExecPay. In other words, Shaaltiel earned more than 33.6% of executives.

ClassificationRankingPercentile
All
8,656
out of 13,032
34th
Division
Manufacturing
3,216
out of 4,965
35th
Major group
Chemicals And Allied Products
1,091
out of 1,690
35th
Industry group
Drugs
866
out of 1,369
37th
Industry
Biological Products, Except Diagnostic Substances
156
out of 241
35th
Source: SEC filing on March 16, 2017.

Shaaltiel's colleagues

We found four more compensation records of executives who worked with Yoseph Shaaltiel at Protalix BioTherapeutics in 2014.

2014

Yossi Maimon

Protalix BioTherapeutics

Chief Financial Officer

2014

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

2014

Tzvi Palash

Protalix BioTherapeutics

Chief Operating Officer

2014

Moshe Manor

Protalix BioTherapeutics

Chief Executive Officer

News

You may also like